Treatment of right ventricular outflow tract dysfunction: A multimodality approach

Francesca Romana Pluchinotta, Claudio Bussadori, Gianfranco Butera, Luciane Piazza, Massimo Chessa, Antonio Saracino, Javier Fernandez Sarabia, Luca Giugno, Carmelo Arcidiacono, Angelo Micheletti, Diana Gabriela Negura, Vlasta Fesslova, Mario Carminati

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The right timing to replace the pulmonary valve in a patient with dysfunction of the right ventricular outflow tract is unknown. Both percutaneous pulmonary valve and surgical prosthesis are suitable options. In every patient, the right ventricle (RV) remodels and recovers differently after pulmonary replacement. Therefore, it is difficult to identify the best treatment option and to predict the long-term results. In the last few years, we focused our research on optimizing the characterization of these patients through advanced cardiovascular imaging in order to find possible variables, parameters, and reproducible measurements that can help us in the decision-making process. The aim of the present article is to present our ongoing research lines that focus on the characterization and optimal treatment approach to the dysfunction of the RVOT.

Original languageEnglish
Pages (from-to)E22-E26
JournalEuropean Heart Journal, Supplement
Volume18
DOIs
Publication statusPublished - Apr 28 2016

Fingerprint

Pulmonary Valve
Right Ventricular Dysfunction
Research
Prostheses and Implants
Heart Ventricles
Decision Making
Therapeutics
Lung

Keywords

  • Percutaneous pulmonary valve replacement
  • Pulmonary valve
  • Rright ventricle

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Treatment of right ventricular outflow tract dysfunction : A multimodality approach. / Pluchinotta, Francesca Romana; Bussadori, Claudio; Butera, Gianfranco; Piazza, Luciane; Chessa, Massimo; Saracino, Antonio; Fernandez Sarabia, Javier; Giugno, Luca; Arcidiacono, Carmelo; Micheletti, Angelo; Negura, Diana Gabriela; Fesslova, Vlasta; Carminati, Mario.

In: European Heart Journal, Supplement, Vol. 18, 28.04.2016, p. E22-E26.

Research output: Contribution to journalArticle

Pluchinotta, FR, Bussadori, C, Butera, G, Piazza, L, Chessa, M, Saracino, A, Fernandez Sarabia, J, Giugno, L, Arcidiacono, C, Micheletti, A, Negura, DG, Fesslova, V & Carminati, M 2016, 'Treatment of right ventricular outflow tract dysfunction: A multimodality approach', European Heart Journal, Supplement, vol. 18, pp. E22-E26. https://doi.org/10.1093/eurheartj/suw019
Pluchinotta, Francesca Romana ; Bussadori, Claudio ; Butera, Gianfranco ; Piazza, Luciane ; Chessa, Massimo ; Saracino, Antonio ; Fernandez Sarabia, Javier ; Giugno, Luca ; Arcidiacono, Carmelo ; Micheletti, Angelo ; Negura, Diana Gabriela ; Fesslova, Vlasta ; Carminati, Mario. / Treatment of right ventricular outflow tract dysfunction : A multimodality approach. In: European Heart Journal, Supplement. 2016 ; Vol. 18. pp. E22-E26.
@article{cbfc722b21c046079c5fd47e7d84c07f,
title = "Treatment of right ventricular outflow tract dysfunction: A multimodality approach",
abstract = "The right timing to replace the pulmonary valve in a patient with dysfunction of the right ventricular outflow tract is unknown. Both percutaneous pulmonary valve and surgical prosthesis are suitable options. In every patient, the right ventricle (RV) remodels and recovers differently after pulmonary replacement. Therefore, it is difficult to identify the best treatment option and to predict the long-term results. In the last few years, we focused our research on optimizing the characterization of these patients through advanced cardiovascular imaging in order to find possible variables, parameters, and reproducible measurements that can help us in the decision-making process. The aim of the present article is to present our ongoing research lines that focus on the characterization and optimal treatment approach to the dysfunction of the RVOT.",
keywords = "Percutaneous pulmonary valve replacement, Pulmonary valve, Rright ventricle",
author = "Pluchinotta, {Francesca Romana} and Claudio Bussadori and Gianfranco Butera and Luciane Piazza and Massimo Chessa and Antonio Saracino and {Fernandez Sarabia}, Javier and Luca Giugno and Carmelo Arcidiacono and Angelo Micheletti and Negura, {Diana Gabriela} and Vlasta Fesslova and Mario Carminati",
year = "2016",
month = "4",
day = "28",
doi = "10.1093/eurheartj/suw019",
language = "English",
volume = "18",
pages = "E22--E26",
journal = "European Heart Journal, Supplement",
issn = "1520-765X",
publisher = "Oxford University Press",

}

TY - JOUR

T1 - Treatment of right ventricular outflow tract dysfunction

T2 - A multimodality approach

AU - Pluchinotta, Francesca Romana

AU - Bussadori, Claudio

AU - Butera, Gianfranco

AU - Piazza, Luciane

AU - Chessa, Massimo

AU - Saracino, Antonio

AU - Fernandez Sarabia, Javier

AU - Giugno, Luca

AU - Arcidiacono, Carmelo

AU - Micheletti, Angelo

AU - Negura, Diana Gabriela

AU - Fesslova, Vlasta

AU - Carminati, Mario

PY - 2016/4/28

Y1 - 2016/4/28

N2 - The right timing to replace the pulmonary valve in a patient with dysfunction of the right ventricular outflow tract is unknown. Both percutaneous pulmonary valve and surgical prosthesis are suitable options. In every patient, the right ventricle (RV) remodels and recovers differently after pulmonary replacement. Therefore, it is difficult to identify the best treatment option and to predict the long-term results. In the last few years, we focused our research on optimizing the characterization of these patients through advanced cardiovascular imaging in order to find possible variables, parameters, and reproducible measurements that can help us in the decision-making process. The aim of the present article is to present our ongoing research lines that focus on the characterization and optimal treatment approach to the dysfunction of the RVOT.

AB - The right timing to replace the pulmonary valve in a patient with dysfunction of the right ventricular outflow tract is unknown. Both percutaneous pulmonary valve and surgical prosthesis are suitable options. In every patient, the right ventricle (RV) remodels and recovers differently after pulmonary replacement. Therefore, it is difficult to identify the best treatment option and to predict the long-term results. In the last few years, we focused our research on optimizing the characterization of these patients through advanced cardiovascular imaging in order to find possible variables, parameters, and reproducible measurements that can help us in the decision-making process. The aim of the present article is to present our ongoing research lines that focus on the characterization and optimal treatment approach to the dysfunction of the RVOT.

KW - Percutaneous pulmonary valve replacement

KW - Pulmonary valve

KW - Rright ventricle

UR - http://www.scopus.com/inward/record.url?scp=84966570583&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84966570583&partnerID=8YFLogxK

U2 - 10.1093/eurheartj/suw019

DO - 10.1093/eurheartj/suw019

M3 - Article

AN - SCOPUS:84966570583

VL - 18

SP - E22-E26

JO - European Heart Journal, Supplement

JF - European Heart Journal, Supplement

SN - 1520-765X

ER -